Are you a good fit for VITAL?

With VITAL, you can step into the forefront of tomorrow's patient care solutions.

Are you the right fit for the VITAL test-​and-​learn process?

Innovators - test - learn

Does your product or idea support one of our focus areas?

Cardiology, oncology, women’s services, chronic condi­tions such as COPD and diabetes, person­al­ized medi­cine, and clin­ical trans­for­ma­tion

Is your product or idea commercially available?

If you already have commer­cial approval for your medical solu­tion, but seek wide­spread adop­tion by the medical commu­nity, VITAL can help. We consider solu­tions in these cate­gories:

  • Device
  • Health IT Solution
  • Therapeutic
  • Diagnostic
  • Care Delivery Solution

Do you need real-​world evidence to speed up market adoption?

Clinicians and health plans need to have confi­dence in your solu­tion before they will accept it as a new care stan­dard. VITAL can help you gather the evidence you need to show how it improves patient care. And we collab­o­rate with doctors who run tests with real patients.

Process & Offerings

1

Solutions discovery

Tell us about your product or idea. Submit a summary of your project via email, including a problem description, value proposition, proposed solution, timeline, and budget.

Evaluation criteria
  • Competitive land­scape
  • Market analysis
  • Strategic oppor­tu­nity
  • Member popu­la­tion impacted
  • Potential utiliza­tion
  • PMPM medical and RX cost impact esti­mates

Accepted to proceed

2

Test design

Companies accepted into the VITAL process will work closely with us to design the test process, while VITAL performs a rigorous opportunity assessment.

What you get from VITAL
  • Data oppor­tu­nity sizing assess­ment
  • Compliance veri­fi­ca­tion
  • Enterprise value assess­ment
  • Competitive land­scape
  • Market level assess­ment (MLA)

Board approves test

3

Evidence delivery

VITAL orchestrates testing and delivers comprehensive clinical, cost, and experience data.

What you get from VITAL
  • Test design
  • Statistical and data analysis plan
  • Implementation play­book
  • Clinical, cost, and patient expe­ri­ence outcomes report
  • Insights and inter­pre­ta­tions
Evaluation criteria
  • Competitive land­scape
  • Market analysis
  • Strategic oppor­tu­nity
  • Member popu­la­tion impacted
  • Potential utiliza­tion
  • PMPM medical and RX cost impact esti­mates
What you get from VITAL
  • Data oppor­tu­nity sizing assess­ment
  • Compliance veri­fi­ca­tion
  • Enterprise value assess­ment
  • Competitive land­scape
  • Market level assess­ment (MLA)
What you get from VITAL
  • Test design
  • Statistical and data analysis plan
  • Implementation play­book
  • Clinical, cost, and patient expe­ri­ence outcomes report
  • Insights and inter­pre­ta­tions

Benefits for technology leaders

Access to a leading, integrated clinician system and target populations, including:

  • More than 2,800 clin­i­cians across 8 hospi­tals. We collab­o­rate with Allegheny Health Network, plus inde­pen­dent physi­cians and strategic part­ners.
  • Claims and other longi­tu­dinal data of eligible members who partic­i­pate in the program from the largest commer­cial health plan in Pennsylvania.

Seamless continuation from clinical trial to adoption

  • From initial market level and viability assess­ments to action­able test-​and-​learn outcomes, VITAL provides the evidence to navi­gate the clin­ical, economic, and reim­burse­ment land­scape.
  • We can fast-​track your idea through the process and help accel­erate market adop­tion.

Advanced health and cost analytics

  • At VITAL, we have the ability to track and measure cost, quality outcomes, and expe­ri­ence data. We deter­mine how your idea may impact medical spending. 
  • Because of our rela­tion­ships, we are uniquely posi­tioned to provide guid­ance on navi­gating the complex clin­ical, economic, and reim­burse­ment land­scape of the health care industry.

Testimonials

Torax Medical and physi­cian thought leaders have collab­o­rated … building a strong scien­tific foun­da­tion of evidence to support the safety and effi­cacy of the LINX proce­dure. GERD patients who do not respond to medical ther­a­pies can create a tremen­dous cost burden on a health care system and are often at higher risks for compli­ca­tions resulting from not fully treating their disease.”

Todd Berg

President and CEO of Torax Medical

We are very excited to see such lasting results from a 1-​month, drug-​free treat­ment that can dramat­i­cally improve the quality of life for our patients and reduce total medical costs. It was also very promising to see high ther­a­pist and patient satis­fac­tion and 85 percent patient adher­ence, confirming that using Freespira® as a first line treat­ment for panic disorder and panic attacks makes good sense clin­i­cally and finan­cially.”

Anthony P. Mannarino

PhD, Professor and Vice Chair, Department of Psychiatry, Allegheny General Hospital

In the begin­ning, when I heard about HeartFlow®, I wanted to talk to my divi­sion chief, Dr. Srinivas Murali, about exploring it. But then I heard that Highmark Health and VITAL were already talking to HeartFlow®, which is a company from California. They needed a physi­cian cham­pion to put HeartFlow® to the test, and I expressed interest.”

Monreal Shah

Co-director of Cardiovascular MRI, Allegheny Health Network

Frequently Asked Questions

What is the VITAL program?

VITAL lever­ages claims-​level and clin­ical data to produce evidence for commer­cially avail­able prod­ucts (devices, tests, and processes) that have not been widely adopted. The VITAL team designs targeted, accel­er­ated, real-​word tests to gathers inte­grated clin­ical, medical cost, and patient expe­ri­ence data. Collaborators then eval­uate the prod­ucts’ clin­ical and cost-​effectiveness and make recom­men­da­tions for market adop­tion.

How long are VITAL tests?

The typical eval­u­a­tion processes takes 6 – 18 months, depending on the quality of evidence avail­able for review prior to test launch. The VITAL team eval­u­ates new solu­tions and conducts tests in parallel as capacity allows.

What types of solutions are tested?

The VITAL team eval­u­ates health care tech­nolo­gies, labs, and/​or processes that are commer­cially avail­able and have received FDA approval — or other certi­fi­ca­tion equiv­a­lents (e.g., CLIA certi­fi­ca­tion for labs) — but have not yet received coverage under most health plan medical poli­cies. We prior­i­tize candi­dates based on how a company’s needs match with our capa­bil­i­ties. We currently do not test phar­ma­ceu­tical ther­a­pies.

What has VITAL tested so far and what is currently in the VITAL program's pipeline?

As of January 2018, more than 40 new ideas were under eval­u­a­tion or under devel­op­ment. Additional growth is expected as our program continues to scale. By 2020, the team hopes to manage more than 10 inno­va­tion projects annu­ally.

See More